Metric Finance
LearnFAQ
LearnFAQ

Learn / TRLV

NYSE: TRLV

Trulieve Cannabis (TRLV) stock, explained like you're 5

Trulieve Cannabis trades on the New York Stock Exchange under the ticker TRLV. It is a mid cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.

Ticker
TRLV
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Medicinal Chemicals and Botanical Products
Size
Mid cap, about 2.1 billion dollars

Is Trulieve Cannabis a small, medium or large cap company?

No. Trulieve Cannabis is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Trulieve Cannabis makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves TRLV stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Top Trulieve Cannabis (TRLV) Competitors 2026 (MarketBeat)
  • symbol__ Stock Quote Price and Forecast (CNN)
  • Mortgage Payoff Might Change The Case For Investing In Trulieve Stock (TRLV) (Simply Wall Street)
  • TRLV Stock Price and Chart NYSE:TRLV (TradingView)
  • Trulieve Reports Second Quarter 2026 Results Investors (Trulieve)

Follow TRLV in your daily brief

Each trading day at 5 PM ET we post what happened to Trulieve Cannabis and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow TRLV

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Trulieve Cannabis stock

What does Trulieve Cannabis do?

Trulieve Cannabis trades on the New York Stock Exchange under the ticker TRLV. It is a mid cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.

What is the ticker symbol for Trulieve Cannabis?

Trulieve Cannabis trades under the ticker TRLV on the New York Stock Exchange.

What is Trulieve Cannabis's market cap?

Trulieve Cannabis is a mid cap stock with a market cap of about 2.1 billion dollars.

How does Trulieve Cannabis make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves TRLV stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow TRLV stock every day?

Add TRLV to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow TRLV daily

A free brief on Trulieve Cannabis and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • BTI · British American Tobacco p.l.c.
  • DFTX · Definium Therapeutics
  • RGC · Regencell Bioscience Holdings Ltd
  • RLX · RLX Technology

Similar stocks

  • BTIBritish American Tobacco p.l.c.
  • DFTXDefinium Therapeutics
  • RGCRegencell Bioscience Holdings Ltd
  • RLXRLX Technology

Compare TRLV: TRLV vs BTI, TRLV vs DFTX, TRLV vs RGC

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed